Larvol Delta - Biocardia-Phase-3-CardiAMPHF-Trial-of-Novel-Cardiac-Cell-Therapy-for-Ischemic-Heart-Failure-Shows-Increased-Survival-Decreased-Cardiac-Events-and-Improved-Quality-of-Life-at-Two-Years

CardiAMP Cell Therapy (BCDA-02) - BioCardia

https://www.globenewswire.com/news-release/2025/03/31/3052241/0/en/Biocardia-Phase-3-CardiAMP-HF-Trial-of-Novel-Cardiac-Cell-Therapy-for-Ischemic-Heart-Failure-Shows-Increased-Survival-Decreased-Cardiac-Events-and-Improved-Quality-of-Life-at-Two-Y.html

Mar 31, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next